cvt 124 has been researched along with hydrochlorothiazide in 1 studies
Studies (cvt 124) | Trials (cvt 124) | Recent Studies (post-2010) (cvt 124) | Studies (hydrochlorothiazide) | Trials (hydrochlorothiazide) | Recent Studies (post-2010) (hydrochlorothiazide) |
---|---|---|---|---|---|
18 | 2 | 0 | 6,921 | 2,165 | 1,262 |
Protein | Taxonomy | cvt 124 (IC50) | hydrochlorothiazide (IC50) |
---|---|---|---|
Carbonic anhydrase 2 | Homo sapiens (human) | 5.4954 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brooks, DP; DeWolf, R; Fletcher, T; Gellai, M; Ruffolo, RR; Schreiner, GF | 1 |
1 other study(ies) available for cvt 124 and hydrochlorothiazide
Article | Year |
---|---|
CVT-124, a novel adenosine A1 receptor antagonist with unique diuretic activity.
Topics: Animals; Diuretics; Dose-Response Relationship, Drug; Furosemide; Glomerular Filtration Rate; Hydrochlorothiazide; Male; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Renal Circulation; Xanthines | 1998 |